The compiler infers, but does not take instructions. There is no syntax for explicit type declarations yet, and the new type ...

The Java Community Process formally launches development of Java SE 28, with Project Valhalla once again positioned as the release's most closely watched feature.

Artificial intelligence has moved quickly from experimentation to real use inside the finance function. Controllers, chief accounting officers and CFOs are being asked to evaluate how AI can support ...

Amarin Pharma has not done enough to definitively show that its generic competitor, Hikma Pharmaceuticals, is infringing on Amarin's patents for its anti-hypertriglyceridemia drug icosapent ethyl ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

The percentage of failing grades in multiple UC Berkeley computer science classes in spring 2026 is significantly higher than past semesters and marks a departure from the department’s grading ...

May 21 (Reuters) - Hims & Hers Health (HIMS.N), opens new tab said on Thursday it is now offering Canadians a generic version of semaglutide, the active ingredient in Novo Nordisk's (NOVOb.CO), opens ...

Jury finds Takeda liable to drug purchasers and insurers Case marks first jury verdict against drugmaker in reverse payment antitrust class action 2014 patent settlement with Par delayed generic ...

BOSTON, May 18 (Reuters) - A U.S. jury on Monday found Takeda Pharmaceutical ⁠liable ⁠for causing about $885 million in damages by delaying ⁠a generic version of its constipation drug Amitiza through ...

If you haven't seen the latest Java developer productivity report from Perforce, you should check it out. Written by Perforce CTO Rod Cope and developer tools exec Jeff Michael, the "2025 Java ...

Novo Nordisk A/S expects generic Ozempic to be delayed in China until next year, a positive step for the drugmaker as it battles to keep its share of the global obesity market. The patent for ...

A Supreme Court case heard this week could give brand-name drugmakers longer monopolies, delay generic competition, and leave patients paying higher prices. When it comes to generic medications, ...